(Rac)-AMG8379
CAS No. 1641574-26-6
(Rac)-AMG8379( (Rac)-AMG8380 )
Catalog No. M26409 CAS No. 1641574-26-6
(Rac)-AMG8379 is a racemate of AMG8379. AMG8379 is a potent, orally active and selective sulfonamide NaV1.7 antagonist(hNaV1.7 and mNaV1.7 with IC50s of 8.5 and 18.6 nM , respectively ).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 540 | In Stock |
|
| 2MG | 278 | In Stock |
|
| 5MG | 426 | In Stock |
|
| 10MG | 625 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1283 | In Stock |
|
| 100MG | 1758 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3515 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(Rac)-AMG8379
-
NoteResearch use only, not for human use.
-
Brief Description(Rac)-AMG8379 is a racemate of AMG8379. AMG8379 is a potent, orally active and selective sulfonamide NaV1.7 antagonist(hNaV1.7 and mNaV1.7 with IC50s of 8.5 and 18.6 nM , respectively ).
-
Description(Rac)-AMG8379 is a racemate of AMG8379. AMG8379 is a potent, orally active and selective sulfonamide NaV1.7 antagonist(hNaV1.7 and mNaV1.7 with IC50s of 8.5 and 18.6 nM , respectively ).
-
In Vitro——
-
In Vivo——
-
Synonyms(Rac)-AMG8380
-
PathwayOthers
-
TargetOther Targets
-
RecptorATF4| ATF6| ERK| GRP78| MMP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1641574-26-6
-
Formula Weight543.93
-
Molecular FormulaC25H16ClF2N3O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=S(NC1=NOC=C1)(C2=CC(C=CC(N3C4=CC(F)=C(C=C4OC)C5=CC(Cl)=CC(F)=C5)=O)=C3C=C2)=O.[Racemate]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang B, Han H, et al. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis. Biochem Pharmacol. 2016 Mar 15;104:8-18.
molnova catalog
related products
-
N3-Ph-NHS ester
N3-Ph-NHS ester is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
-
Fibrinogen-Binding P...
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor.?Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin
-
EcDsbB-IN-12
EcDsbB-IN-12 targets disulfide bond forming enzyme,and is a novel potent specific inhibitor of EcDsbB.
Cart
sales@molnova.com